← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TAMARANG SA · Approved 2026-05-12

Drug application

FDA Application #

ANDA215260

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUGAMMADEX

Generic name

Sugammadex

Active ingredients

SUGAMMADEX

Dosage form

INJECTION

Route

—

Marketing status

None (Tentative Approval)

Sponsor

TAMARANG SA

First approval

2026-05-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown